Humacyte lawsuite is questionableAs a scientist, I have been in medical device development and manufacturing. Every company faces ups and downs in manufacturing medical devices. FDA regularly visits those companies for audits. As an investor, I hired and a FDA compliance expert about two weeks ago to analyze the FDA findings and decide whether I shall sell my shares. According to the expert, the FDA findings were not significant and the issues could have been fixed easily. I humbly think that Humacyte management did not own to it shareholders for disclosing such non-significant and easily fixable nuances. As such, I have been keeping my shares in the stock. My two cents on this topic.
